| scholarly article | Q13442814 |
| P50 | author | Won Joo Choe | Q42355498 |
| Vesna Jevtovic-Todorovic | Q60642341 | ||
| Veit-Simon Eckle | Q88088249 | ||
| P2093 | author name string | Slobodan M Todorovic | |
| Reza Salajegheh | |||
| Aleksandar Obradovic | |||
| Emily Leach | |||
| Richard B Messinger | |||
| P2860 | cites work | Molecular characterization of a neuronal low-voltage-activated T-type calcium channel | Q24316054 |
| Cloning and characterization of alpha1H from human heart, a member of the T-type Ca2+ channel gene family | Q24316347 | ||
| Molecular physiology of low-voltage-activated t-type calcium channels | Q28200827 | ||
| Attenuated pain responses in mice lacking Ca(V)3.2 T-type channels | Q28260743 | ||
| Characterization of ethosuximide reduction of low-threshold calcium current in thalamic neurons | Q28342691 | ||
| Mechanical and thermal antinociception in rats following systemic administration of mibefradil, a T-type calcium channel blocker | Q30309941 | ||
| Potent analgesic effects of anticonvulsants on peripheral thermal nociception in rats | Q30311218 | ||
| Redox modulation of peripheral T-type Ca2+ channels in vivo: alteration of nerve injury-induced thermal hyperalgesia | Q30433597 | ||
| 5beta-reduced neuroactive steroids are novel voltage-dependent blockers of T-type Ca2+ channels in rat sensory neurons in vitro and potent peripheral analgesics in vivo | Q30434076 | ||
| Selective T-type calcium channel blockade alleviates hyperalgesia in ob/ob mice | Q30434283 | ||
| In vivo silencing of the Ca(V)3.2 T-type calcium channels in sensory neurons alleviates hyperalgesia in rats with streptozocin-induced diabetic neuropathy | Q30434954 | ||
| The endogenous redox agent L-cysteine induces T-type Ca2+ channel-dependent sensitization of a novel subpopulation of rat peripheral nociceptors. | Q30438110 | ||
| The role of peripheral T-type calcium channels in pain transmission | Q30440753 | ||
| Cell-specific alterations of T-type calcium current in painful diabetic neuropathy enhance excitability of sensory neurons | Q30443224 | ||
| Reducing agents sensitize C-type nociceptors by relieving high-affinity zinc inhibition of T-type calcium channels | Q30444180 | ||
| Nickel block of three cloned T-type calcium channels: low concentrations selectively block alpha1H. | Q30447500 | ||
| Free radical signalling underlies inhibition of CaV3.2 T-type calcium channels by nitrous oxide in the pain pathway | Q30452208 | ||
| Ion channels of nociception. | Q33547278 | ||
| Diabetic neuropathy: mechanisms to management | Q33554384 | ||
| Pharmacological properties of T-type Ca2+ current in adult rat sensory neurons: effects of anticonvulsant and anesthetic agents | Q34451739 | ||
| Nitrous oxide (laughing gas) is an NMDA antagonist, neuroprotectant and neurotoxin | Q34464493 | ||
| On the action of the anti-absence drug ethosuximide in the rat and cat thalamus. | Q34472682 | ||
| Early painful diabetic neuropathy is associated with differential changes in tetrodotoxin-sensitive and -resistant sodium channels in dorsal root ganglion neurons in the rat. | Q35688088 | ||
| The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions. | Q35824087 | ||
| Pharmacological dissection and distribution of NaN/Nav1.9, T-type Ca2+ currents, and mechanically activated cation currents in different populations of DRG neurons | Q36295971 | ||
| Pharmacology and drug discovery for T-type calcium channels | Q36683558 | ||
| Towards the discovery of novel T-type calcium channel blockers. | Q36804457 | ||
| In vitro characterization of T-type calcium channel antagonist TTA-A2 and in vivo effects on arousal in mice. | Q39671872 | ||
| Kurtoxin, a gating modifier of neuronal high- and low-threshold ca channels. | Q40653150 | ||
| Redox modulation of T-type calcium channels in rat peripheral nociceptors | Q40787127 | ||
| Selective T-type calcium channel block in thalamic neurons reveals channel redundancy and physiological impact of I(T)window | Q40873132 | ||
| Silencing of the Cav3.2 T-type calcium channel gene in sensory neurons demonstrates its major role in nociception. | Q40949695 | ||
| Cloning and expression of a novel member of the low voltage-activated T-type calcium channel family | Q40969230 | ||
| Properties of Ba2+ currents arising from human alpha1E and alpha1Ebeta3 constructs expressed in HEK293 cells: physiology, pharmacology, and comparison to native T-type Ba2+ currents | Q40991791 | ||
| Discovery and main pharmacological properties of mibefradil (Ro 40-5967), the first selective T-type calcium channel blocker. | Q41711953 | ||
| Reversal of experimental neuropathic pain by T-type calcium channel blockers | Q44589954 | ||
| Thalamic Control of Visceral Nociception Mediated by T-Type Ca 2+ Channels | Q44606624 | ||
| Rapid onset pain induced by intravenous streptozotocin in the rat | Q44658686 | ||
| Design, synthesis, and evaluation of a novel 4-aminomethyl-4-fluoropiperidine as a T-type Ca2+ channel antagonist | Q46550414 | ||
| Enantioselective blockade of T-type Ca2+ current in adult rat sensory neurons by a steroid that lacks gamma-aminobutyric acid-modulatory activity | Q48357310 | ||
| Contrasting biophysical and pharmacological properties of T-type and R-type calcium channels. | Q48666040 | ||
| Plasticity of sodium channel expression in DRG neurons in the chronic constriction injury model of neuropathic pain | Q48905791 | ||
| Inhibition of T-type voltage-gated calcium channels by a new scorpion toxin | Q48921080 | ||
| Nickel block of a family of neuronal calcium channels: subtype- and subunit-dependent action at multiple sites. | Q49012811 | ||
| Inhibition of neuropathic pain by decreased expression of the tetrodotoxin-resistant sodium channel, NaV1.8. | Q51338352 | ||
| Anticonvulsants but not general anesthetics have differential blocking effects on different T-type current variants. | Q51395959 | ||
| Role of T-Type Calcium Current in Identified D-Hair Mechanoreceptor Neurons Studied In Vitro | Q56980269 | ||
| Amiloride selectively blocks the low threshold (T) calcium channel | Q69022800 | ||
| Mechanisms of neuropathic pain | Q79173262 | ||
| P433 | issue | 5 | |
| P304 | page(s) | 900-910 | |
| P577 | publication date | 2011-08-05 | |
| P1433 | published in | Molecular Pharmacology | Q1943386 |
| P1476 | title | TTA-P2 is a potent and selective blocker of T-type calcium channels in rat sensory neurons and a novel antinociceptive agent | |
| P478 | volume | 80 |
| Q37074848 | (S)-lacosamide inhibition of CRMP2 phosphorylation reduces postoperative and neuropathic pain behaviors through distinct classes of sensory neurons identified by constellation pharmacology |
| Q40057939 | A Randomized, Double-Blind, Placebo-Controlled, Crossover Study of the T-Type Calcium Channel Blocker ABT-639 in an Intradermal Capsaicin Experimental Pain Model in Healthy Adults |
| Q47957480 | A mixed Ca2+ channel blocker, A-1264087, utilizes peripheral and spinal mechanisms to inhibit spinal nociceptive transmission in a rat model of neuropathic pain |
| Q39290501 | AKAP-dependent sensitization of Ca(v) 3.2 channels via the EP(4) receptor/cAMP pathway mediates PGE(2) -induced mechanical hyperalgesia |
| Q64267877 | Activity of T-type calcium channels is independent of CRMP2 in sensory neurons |
| Q35671899 | Adrenal fasciculata cells express T-type and rapidly and slowly activating L-type Ca2+ channels that regulate cortisol secretion |
| Q47950985 | CRISPR/Cas9 editing of Nf1 gene identifies CRMP2 as a therapeutic target in neurofibromatosis type 1-related pain that is reversed by (S)-Lacosamide |
| Q30528512 | CRMP-2 peptide mediated decrease of high and low voltage-activated calcium channels, attenuation of nociceptor excitability, and anti-nociception in a model of AIDS therapy-induced painful peripheral neuropathy |
| Q52431558 | CRMP2-Neurofibromin Interface Drives NF1-related Pain. |
| Q96585164 | Ca2+ entry through NaV channels generates submillisecond axonal Ca2+ signaling |
| Q88171884 | CaV3.1 isoform of T-type calcium channels supports excitability of rat and mouse ventral tegmental area neurons |
| Q30413912 | CaV3.2 T-type calcium channels in peripheral sensory neurons are important for mibefradil-induced reversal of hyperalgesia and allodynia in rats with painful diabetic neuropathy |
| Q38175134 | Calcium-permeable ion channels in pain signaling |
| Q38187012 | Cav3 T-type channels: regulators for gating, membrane expression, and cation selectivity |
| Q58606217 | Cell-Type Specific Distribution of T-Type Calcium Currents in Lamina II Neurons of the Rat Spinal Cord |
| Q60713082 | Characterisation of rebound depolarisation in mice deep dorsal horn neurons in vitro |
| Q47784510 | Control of firing patterns through modulation of axon initial segment T-type calcium channels |
| Q55271738 | Cytosolic ATP Relieves Voltage-Dependent Inactivation of T-Type Calcium Channels and Facilitates Excitability of Neurons in the Rat Central Medial Thalamus. |
| Q48000226 | Dissecting the role of the CRMP2-neurofibromin complex on pain behaviors. |
| Q38861595 | Enhanced BDNF signalling following chronic hypoxia potentiates catecholamine release from cultured rat adrenal chromaffin cells |
| Q36036070 | GABAergic synaptic transmission triggers action potentials in thalamic reticular nucleus neurons |
| Q26783154 | Genetic disruption of voltage-gated calcium channels in psychiatric and neurological disorders |
| Q37476509 | Heantos-4, a natural plant extract used in the treatment of drug addiction, modulates T-type calcium channels and thalamocortical burst-firing |
| Q37150371 | Heterogeneous Expression of T-type Ca(2+) Channels Defines Different Neuronal Populations in the Inferior Olive of the Mouse |
| Q30410268 | Immunohistological demonstration of CaV3.2 T-type voltage-gated calcium channel expression in soma of dorsal root ganglion neurons and peripheral axons of rat and mouse |
| Q36823117 | Inflammatory mediator bradykinin increases population of sensory neurons expressing functional T-type Ca(2+) channels |
| Q30371210 | Inhibition of CaV3.2 T-type calcium channels in peripheral sensory neurons contributes to analgesic properties of epipregnanolone. |
| Q42508518 | Intrinsic membrane properties and cholinergic modulation of mouse basal forebrain glutamatergic neurons in vitro |
| Q37313614 | NG2 glial cells integrate synaptic input in global and dendritic calcium signals |
| Q30456403 | Neuropathic pain: role for presynaptic T-type channels in nociceptive signaling |
| Q37623368 | Nociceptive neurons differentially express fast and slow T-type Ca²⁺ currents in different types of diabetic neuropathy |
| Q37023620 | Painful nerve injury decreases sarco-endoplasmic reticulum Ca²⁺-ATPase activity in axotomized sensory neurons |
| Q96136089 | Pathophysiological roles and therapeutic potential of voltage-gated ion channels (VGICs) in pain associated with herpesvirus infection |
| Q30422994 | Presynaptic Cav3.2 channels regulate excitatory neurotransmission in nociceptive dorsal horn neurons |
| Q39154350 | Recent advances in the development of T-type calcium channel blockers for pain intervention. |
| Q38239508 | Recent patents on calcium channel blockers: emphasis on CNS diseases. |
| Q27308025 | Redox-Dependent Modulation of T-Type Ca(2+) Channels in Sensory Neurons Contributes to Acute Anti-Nociceptive Effect of Substance P |
| Q53070307 | Reduced excitability of gp130-deficient nociceptors is associated with increased voltage-gated potassium currents and Kcna4 channel upregulation. |
| Q38709498 | Regulation of the T-type Ca(2+) channel Cav3.2 by hydrogen sulfide: emerging controversies concerning the role of H2 S in nociception |
| Q30409746 | Reversal of neuropathic pain in diabetes by targeting glycosylation of Ca(V)3.2 T-type calcium channels |
| Q99637393 | SARS-CoV-2 Spike protein co-opts VEGF-A/Neuropilin-1 receptor signaling to induce analgesia |
| Q100427774 | SARS-CoV-2 Spike protein co-opts VEGF-A/Neuropilin-1 receptor signaling to induce analgesia |
| Q89135381 | Selective Blockade of T-Type Ca2+ Channels is Protective Against Alcohol-Withdrawal Induced Seizure and Mortality |
| Q38021306 | Sensory neurons, ion channels, inflammation and the onset of neuropathic pain. |
| Q35189552 | Small organic molecule disruptors of Cav3.2 - USP5 interactions reverse inflammatory and neuropathic pain. |
| Q30276331 | Small-Conductance Ca2+-Activated Potassium Channels Negatively Regulate Aldosterone Secretion in Human Adrenocortical Cells |
| Q42494125 | Sub-synaptic localization of Cav3.1 T-type calcium channels in the thalamus of normal and parkinsonian monkeys |
| Q39168504 | Sustained relief of ongoing experimental neuropathic pain by a CRMP2 peptide aptamer with low abuse potential. |
| Q58711077 | Synthesis and biological evaluation of pyrrolidine-based T-type calcium channel inhibitors for the treatment of neuropathic pain |
| Q39174362 | Synthesis and characterization of a disubstituted piperazine derivative with T-type channel blocking action and analgesic properties. |
| Q36253337 | T-type Ca2+ channels are required for enhanced sympathetic axon growth by TNFα reverse signalling |
| Q38192954 | T-type calcium channels in chronic pain: mouse models and specific blockers |
| Q38626606 | Targeting voltage-gated calcium channels in neurological and psychiatric diseases |
| Q26781422 | The Physiology, Pathology, and Pharmacology of Voltage-Gated Calcium Channels and Their Future Therapeutic Potential |
| Q38660940 | The role of T-type calcium channels in the subiculum: to burst or not to burst? |
| Q48234830 | Thrombospondin-4 acts on pre-synaptic calcium channel alpha-2-delta-1 subunit to induce synaptogenesis between sensory and spinal cord neurons through a T-type calcium channel dependent pathway that is blocked by early, low-dose gabapentin treatment |
| Q41698769 | Thrombospondin-4 divergently regulates voltage-gated Ca2+ channel subtypes in sensory neurons after nerve injury |
Search more.